Gene-association studies hint at better ways of treating the leading cause of death, but capitalizing on them is proving to be a slow and difficult process. Erika Check Hayden reports.
This is a preview of subscription content, log in via an institution to check access.
References
Anderson, J. L. et al. Circulation 116, 2563-2570 (2007).
Eckman, M. H., Rosand, J., Greenberg, S. M. & Gage, B. F. Ann. Intern. Med. 150, 73-83 (2009).
Collet, J.-P. et al. Lancet 373, 309-317 (2009).
Mega, J. L. et al. N. Engl. J. Med. 360, 354-362 (2009).
Simon, T. et al. N. Engl. J. Med. 360, 363-375 (2009).
Paynter, N. P. et al. Ann. Intern. Med. 150, 65-72 (2009).
Lango, H. et al. Diabetes 57, 3129-3135 (2008).
van Hoek, M. et al. Diabetes 57, 3122-3128 (2008).
Lyssenko, V. et al. N. Engl. J. Med. 359, 2220-2232 (2008).
Mihaescu, R. et al. Genet. Med. advance online publication doi:10.1097/GIM.0b013e3181b13a4f (2009).
Benjamin, E. J. et al. Nature Genet. 41, 879-881 (2009).
Gudbjartsson, D. F. et al. Nature Genet. 41, 876-878 (2009).
Gudbjartsson, D. F. et al. Nature 448, 353-357 (2007).
Related links
Related links
Related links in Nature Research
Personalized medicine for clopidogrel resistance?
Related external links
Rights and permissions
About this article
Cite this article
Check Hayden, E. Cardiovascular disease gets personal. Nature 460, 940–941 (2009). https://doi.org/10.1038/460940a
Published:
Issue Date:
DOI: https://doi.org/10.1038/460940a
- Springer Nature Limited
This article is cited by
-
Only Connect
Molecular Diagnosis & Therapy (2010)